‘Neoadjuvant therapy’ refers to any treatment given before the main treatment (which is usually surgery) for a cancer. The goals of neoadjuvant therapy can include shrinking the cancer, which can potentially make surgery easier, and to reduce the risk of cancer recurrence.
Our Neoadjuvant immunotherapy for melanoma Patient Information leaflet explains all you need to know about neoadjuvant immunotherapy, including what it is, the benefits, the multidisciplinary approach, what to expect before, during and after, common side effects, clinical trials and prognosis.
Click the cover image below to download the PDF.
